Stockscreener 앱 받기
4.12
2.37%
-0.10
시간 외 거래:
4.12
전일 마감가:
$4.22
열려 있는:
$4.16
하루 거래량:
203.95K
Relative Volume:
0.81
시가총액:
$176.68M
수익:
-
순이익/손실:
$-19.90M
주가수익비율:
-7.7736
EPS:
-0.53
순현금흐름:
$-19.80M
1주 성능:
-18.42%
1개월 성능:
+15.41%
6개월 성능:
-28.47%
1년 성능:
+19.42%
1일 변동 폭
$4.0145
$4.17
1주일 범위
$4.0145
$5.60
52주 변동 폭
$3.19
$6.8184
Diamedica Therapeutics Inc Stock (DMAC) Company Profile
명칭
Diamedica Therapeutics Inc
전화
(763) 496-5454
주소
301 CARLSON PARKWAY, MINNEAPOLIS, MN
DMAC을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
DMAC
Diamedica Therapeutics Inc
|
4.12 | 217.29M | 0 | -19.90M | -19.80M | -0.53 |
|
VRTX
Vertex Pharmaceuticals Inc
|
462.13 | 117.32B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.87 | 58.89B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
401.80 | 51.14B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
673.80 | 41.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
299.01 | 32.59B | 3.81B | -644.79M | -669.77M | -6.24 |
Diamedica Therapeutics Inc Stock (DMAC) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-10-07 | 개시 | H.C. Wainwright | Buy |
| 2024-04-24 | 재개 | Craig Hallum | Buy |
| 2023-06-22 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2021-04-09 | 개시 | Oppenheimer | Outperform |
| 2021-02-17 | 개시 | ROTH Capital | Buy |
| 2020-10-30 | 개시 | Guggenheim | Buy |
| 2020-07-08 | 개시 | Maxim Group | Buy |
| 2019-04-30 | 개시 | Dougherty & Company | Buy |
| 2019-03-05 | 개시 | Lake Street | Buy |
모두보기
Diamedica Therapeutics Inc 주식(DMAC)의 최신 뉴스
What is the risk reward ratio of investing in DiaMedica Therapeutics Inc. stockSuperior stock selection - jammulinksnews.com
What makes DiaMedica Therapeutics Inc. stock price move sharplyMaximize profits with strategic stock selection - jammulinksnews.com
What are the technical indicators suggesting about DiaMedica Therapeutics Inc.Market-leading profit generation - jammulinksnews.com
What are analysts’ price targets for DiaMedica Therapeutics Inc. in the next 12 monthsGet exclusive access to expert stock recommendations - jammulinksnews.com
Is this a good reentry point in DiaMedica Therapeutics Inc.Buy Point Strategy with Profit Protection - Newser
What’s the recovery path for long term holders of DiaMedica Therapeutics Inc.Daily Market Momentum and Pressure Analysis - Newser
How volatile is DiaMedica Therapeutics Inc. stock compared to the marketExpert Picks Signals To Watch Now - jammulinksnews.com
Is DiaMedica Therapeutics Inc. stock overvalued or undervaluedRetirement Planning Forecasts For Consistent Profits - jammulinksnews.com
Can trapped investors hope for a rebound in DiaMedica Therapeutics Inc.Free AI Driven Stock Trend Forecast - Newser
Best data tools to analyze DiaMedica Therapeutics Inc. stockFree Long Hold Safe Return Strategy - Newser
Multi factor analysis applied to DiaMedica Therapeutics Inc.Intraday Price Action Forecast Planner - Newser
Real time pattern detection on DiaMedica Therapeutics Inc. stockReal Chart Based Opportunity Identification - Newser
Can momentum traders help lift DiaMedica Therapeutics Inc.Portfolio Review Summary with Five-Year Outlook - Newser
Should I hold or sell DiaMedica Therapeutics Inc. stock in 2025Swing Trade Tips For Consistent Profits - jammulinksnews.com
Analyzing DiaMedica Therapeutics Inc. with risk reward ratio chartsFree Accurate Buy Point for Momentum Stocks - Newser
DiaMedica Therapeutics Inc. (NASDAQ:DMAC) Shares Could Be 25% Below Their Intrinsic Value Estimate - 富途牛牛
Volume spikes in DiaMedica Therapeutics Inc. stock – what they meanDaily Technical Forecast for Quick Gains - Newser
How DiaMedica Therapeutics Inc. stock performs during market volatilityStock Market Watch with Smart Filters - Newser
DiaMedica Therapeutics Inc. Stock Support and Resistance Levels You Should KnowLow Risk Strategy with Smart Entry Zones - Newser
Off-market insider buying at DiaMedica Therapeutics (DMA) - The Globe and Mail
Quant Models Detect Momentum Reversal in DiaMedica Therapeutics Inc.Fast Entry High Potential Stock Alerts Triggered - metal.it
Published on: 2025-07-29 04:31:05 - metal.it
Is DiaMedica Therapeutics Inc. Stock a Smart Buy in 2025 Investment Analysis InsideReversal Alert Based on RSI Indicator Confirmed - metal.it
Diamedica Stock Soars 10.2% on Major Shareholder's Purchase - AInvest
Analyzing DiaMedica Therapeutics Inc. with risk reward ratio charts Intraday Price Action Forecast Planner - Newser
What are the latest earnings results for DiaMedica Therapeutics Inc.Explosive trading opportunities - jammulinksnews.com
How does DiaMedica Therapeutics Inc. compare to its industry peersLightning-fast growth - jammulinksnews.com
Intrinsic Value of DiaMedica Therapeutics Inc. Stock: Is It Undervalued or OvervaluedSafer Investing With Bigger Upside - Newser
DiaMedica therapeutics (DMAC): Trill AB buys $5.4m in shares By Investing.com - Investing.com South Africa
DiaMedica therapeutics (DMAC): Trill AB buys $5.4m in shares - Investing.com
DiaMedica therapeutics (DMAC) shareholder TomEnterprise Private AB buys $10M in stock - Investing.com
DiaMedica Therapeutics Stock (DMAC) Opinions on $30 Million Private Placement - Quiver Quantitative
Diamedica Therapeutics Inc (DMAC) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.93%
0.15%
자본화:
|
볼륨(24시간):